Company
Headquarters: Beijing, China
Employees: 814
CN¥11.52 Billion
CNY as of Jan. 1, 2026
US$1.64 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $216.15 B |
| Boston Scientific Corporation | $140.40 B |
| Stryker | $133.15 B |
| Medtronic | $123.20 B |
| Edwards Lifesciences Corporation | $50.10 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Beijing Wandong Medical Technology Co., Ltd. engages in the research and development, manufacturing, and sale of medical diagnostic service. It offers MRI solutions; radiological imaging solutions, including CT system, CGO series, DR system, DRF system, digital mammography, and mobile X-ray equipment. The company was formerly known as China Resources Wandong Medical Equipment Co., Ltd. The company was founded in 1955 and is based in Beijing, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥1.62 B |
| EBITDA | CN¥165.1 M |
| Gross Profit TTM | CN¥526.1 M |
| Profit Margin | 0.89% |
| Operating Margin | -21.47% |
| Quarterly Revenue Growth | -12.20% |
Beijing Wandong Medical Technology Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600055 wb_incandescent